Enrico Conti
Research Subjects
Enrico Conti has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Carlo Aschele
Department of Oncology, Ospedale S. Andrea, La Spezia
2 shared publications - Francesco Barillaro
Department of General and Emergency Surgery, S. Maria Hospital, Terni-University of Perugia, Italy
2 shared publications - Paolo Dessanti
Histopathology and Cytopathology Division, Azienda Sanitaria Locale N. 5 , La Spezia, Italy
2 shared publications A.C. Moffat
U.SA. and Canada
1 shared publication- Alessandro Pastorino
Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, 16132 Genoa, Italy
1 shared publication - Alessandro Villa
Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida Miami Florida USA
1 shared publication
Latest Publications
- 30 August 2022
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 26 (2) , 410-414
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Background The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5. Results 262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively. Conclusions In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.
- 30 August 2022
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 26 (2) , 410-414
Composite urinary and sexual outcomes after Rezum: an analysis of predictive factors from an Italian multi-centric study
Background The Rezum system is one of the latest minimally invasive surgical treatments for benign prostatic hyperplasia. Methods We retrospectively reviewed all patients who underwent the Rezum treatment in seven different Italian institutions. A successful urinary outcome was defined as: ≥50% improvement in the IPSS <7, improvement in peak flow ≥50% and/or more than 15 ml/s, ≥1-point improvement in the QoL questionnaire and in the absence of perioperative major complications (AUR, transfusion) or postoperative incontinence. A successful sexual outcome was defined as postoperative (latest follow up consultation) antegrade ejaculation or no variation in ejaculatory function and an increase, or stability or max 1 class reduction, in IIEF-5. Results 262 patients were enrolled with a follow-up period of 11 months (IQR 5–15). No early or late serious adverse events (Clavien III–IV) occurred. Early complications occurred in 39.3% of cases, with 4 cases of clot retention and one case of blood transfusion. Urge incontinence was reported by 6 patients (2.2%). A treatment failure requiring re-intervention occurred in 4 cases (1.5%). The preoperative antegrade ejaculation rate was 56.5%, and after the procedure it increased to 78.2%. The increase of ≥1-point in the QoL was achieved in 92.7% of the cases. Optimal urinary and sexual outcomes were achieved in 52.9% and 87.8%, respectively. Conclusions In our series, water vapor intraprostatic injections seem to be an effective and safe procedure.
- Open Access
- 19 March 2021
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 93 (1) , 68-70
Clear-cell renal cell carcinoma single thyroid metastasis: A single-center retrospective analysis and review of the literature
Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland. Report of three cases and review of the literature.
- 19 March 2021
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 93 (1) , 68-70
Open AccessClear-cell renal cell carcinoma single thyroid metastasis: A single-center retrospective analysis and review of the literature
Renal cell carcinoma (RCC) is known to cause metastasis to unusual sites, which can be both synchronous or metachronous. Thyroid gland is a rare site for metastasis. However, RCC is the most common primary neoplasm to metastasize to the Thyroid gland. Report of three cases and review of the literature.
- Open Access
- 30 September 2018
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 90 (3) , 224-226
Primary melanoma of the bladder: Case report and review of the literature
Skin melanoma represents one of the most common and lethal solid tumor. It usually develops on the skin but it can occur in any tissues with melanine- containing-cells (extracutaneous malignant melanoma). Only 4-5% of malignant melanomas originate in extracutaneous tissues, and they have an extremely lethal behavior (1). These non-skin malignant melanomas are rare but extremely aggressive. Primary melanoma of the genitourinary tract accounts for less than 0.2% of all melanomas. To date only 28 cases of primary bladder melanoma (PMM) are described. We report a rare case of PMM of the bladder in a 72 years old man treated with radical cystectomy and immunotherapy with Nivolumab.
- 30 September 2018
- Published by PAGEPress Publications in Archivio Italiano di Urologia e Andrologia
- Vol. 90 (3) , 224-226
Open AccessPrimary melanoma of the bladder: Case report and review of the literature
Skin melanoma represents one of the most common and lethal solid tumor. It usually develops on the skin but it can occur in any tissues with melanine- containing-cells (extracutaneous malignant melanoma). Only 4-5% of malignant melanomas originate in extracutaneous tissues, and they have an extremely lethal behavior (1). These non-skin malignant melanomas are rare but extremely aggressive. Primary melanoma of the genitourinary tract accounts for less than 0.2% of all melanomas. To date only 28 cases of primary bladder melanoma (PMM) are described. We report a rare case of PMM of the bladder in a 72 years old man treated with radical cystectomy and immunotherapy with Nivolumab.
- 1 October 2006
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 18 (5) , 451-460
Experimental Osteomyelitis: What Have We Learned from Animal Studies about the Systemic Treatment of Osteomyelitis?
Clinical trials of systemic antibiotic treatment of osteomyelitis are difficult to perform for many reasons, such as low incidence rate of osteomyelitis, variety of anatomic locations, stage and etiologic agents. In this article, we reviewed the experimental studies on osteomyelitis available in the English medical literature since 1968, to ascertain their actual and potential impact on the treatment of human osteomyelitis. Major results are summarized and topics of major interest, such as reproducibility of animal models, predictive value of animal models, correlation of pharmacokinetics between different animals and humans, and the correlation of outcome between animal and clinical studies are discussed. Most of the reviewed animal models are reproducible and dependable. However, establishing the right dose regimen in animals appeared a critical factor, which might undermine the predictive value of the experimental study. Due to difficulties in comparing results of animal and human studies, the predictive value of animal studies about osteomyelitis is still unclear. However, animal models gave valuable information to the clinician for choosing the minimal duration of antibiotic treatment. Even though the use of antibiotic combinations was associated with better outcome in the majority of animal studies, such a finding seems to have limited impact on clinical practice.
- 1 October 2006
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 18 (5) , 451-460
Experimental Osteomyelitis: What Have We Learned from Animal Studies about the Systemic Treatment of Osteomyelitis?
Clinical trials of systemic antibiotic treatment of osteomyelitis are difficult to perform for many reasons, such as low incidence rate of osteomyelitis, variety of anatomic locations, stage and etiologic agents. In this article, we reviewed the experimental studies on osteomyelitis available in the English medical literature since 1968, to ascertain their actual and potential impact on the treatment of human osteomyelitis. Major results are summarized and topics of major interest, such as reproducibility of animal models, predictive value of animal models, correlation of pharmacokinetics between different animals and humans, and the correlation of outcome between animal and clinical studies are discussed. Most of the reviewed animal models are reproducible and dependable. However, establishing the right dose regimen in animals appeared a critical factor, which might undermine the predictive value of the experimental study. Due to difficulties in comparing results of animal and human studies, the predictive value of animal studies about osteomyelitis is still unclear. However, animal models gave valuable information to the clinician for choosing the minimal duration of antibiotic treatment. Even though the use of antibiotic combinations was associated with better outcome in the majority of animal studies, such a finding seems to have limited impact on clinical practice.
- Open Access
- 1 January 1991
- Published by Cambridge University Press (CUP) in Symposium - International Astronomical Union
- Vol. 143, f1-f14
IAS volume 143 Cover and Front matter
- 1 January 1991
- Published by Cambridge University Press (CUP) in Symposium - International Astronomical Union
- Vol. 143, f1-f14
Open AccessIAS volume 143 Cover and Front matter